Table 1. Distribution and diameter of biopsied lesions in 112 patients with suspected lymphoma.

	Initial presentation lymphoma (n=87)	Relapsed/transformed lymphoma (n=25)
Lymphoid sites
Retroperitoneum	23 (20–130 mm; 40 mm)	5 (15–100 mm; 48 mm)
Neck/cervical	13 (15–80 mm; 33 mm)	—
Mediastinum	11 (30–90 mm; 55 mm)	—
Axilla	8 (10–90 mm; 33 mm)	4 (20–40 mm; 29 mm)
Groin	5 (20–60 mm; 42 mm)	2 (20 mm)
Supraclavicular	4 (10–60 mm; 29 mm)	1 (30 mm)
Spleen	3 (90–120 mm; 103 mm)	—
Porta hepatic	—	1 (20 mm)
Non-lymphoid sites
Chest wall	5 (35–100 mm; 63 mm)	2 (30, 35 mm)
Abdomen	4 (50–100 mm; 72 mm)	2 (50, 60 mm)
Muscle	3 (30–60 mm; 45 mm)	2 (35, 50 mm)
Lung	2 (35, 40 mm)	2 (25, 30 mm)
Adrenal	1 (50, 80 mm)	—
Spine	2 (30, 45 mm)	—
Liver	1 (40 mm)	3 (10–20 mm; 15 mm)
Bone	1 (100 mm)	—
Kidney	1 (30 mm)	1 (35 mm)

Numbers without parentheses correspond to number of patients. Numbers in parentheses correspond to lesion diameters, or diameter ranges with mean diameters.

Lesion size is defined by largest axis diameter.